Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Vistin Pharma Enters into a Long-term Renewable Energy Supply Agreement with Statkraft
Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term […]
Graciela Racaro Joins Signant Health as Chief Operating Officer
Signant Health, the leader in evidence generation for modern clinical trials, has announced the appointment […]
Stride Health Appoints Peter V. Lee, Former Executive Director of Covered California, to Board of Directors
Stride Health, the leader in portable benefits technology, announced the appointment of Peter V. Lee […]
Molecular Devices Acquires Cellesce, Expanding Industrywide Accessibility to Organoids
Molecular Devices, a leading provider of high-performance life science solutions, has announced the acquisition of […]
CDR-Life Announces the Appointment of Nicole Onetto, MD, MSc, to Board of Directors
CDR-Life, a biotechnology company pioneering a new and differentiated class of highly tumor-selective immuno-oncology therapeutics […]
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Dantari, a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and […]
Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics
Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]
ExPLoRNA Therapeutics Receives Funding to Advance its Novel mRNA Technology
ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, […]
Ankyra Therapeutics Appoints Leisha A. Emens, M.D., Ph.D., as Senior Vice President, Translational Research
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, today […]
GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification
GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more